New technologies in Multiple Sclerosis drug discovery
How HTRF and Alpha Technologies have contributed to MS drug discovery.
Life Science stories
Therapeutic Strategies for Fibrotic Diseases
AlphaScreen® SureFire® pERK and HTRF® cGMP kits were used to better u...
When AlphaLISA and HTRF meet inflammatory bowel di...
Inflammation of the digestive tract wall due to an overactivation of the...
Key facts about neuroinflammation involvement in A...
Discover this blog article to learn more about the neuroinflammation inv...
New hope for Huntington’s disease drug discovery
Use of HTRF to help find a new model using the cellular autophagy mechan...
Retinoic Acid focus yields insight into neuroinfla...
Neuropsychiatric disorders often stem from or feed on neuroinflammatory ...
Inflammation pathway reading, the way to tackle au...
An insight into published inflammatory signaling research.
Kinase investigations open new doors in Oncology a...
Research on kinases: the peer review
Cytokines: an open gate to autoimmune disease ther...
Identification of cytokine-signaling inhibitors contributes a great deal...